血小板增多症-话题@MedSci - 梅斯（MedSci）

#血小板增多症#

15篇内容 | 1232人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2028510, encodeId=d9bf202851016, content=<a href='/topic/show?id=b3eb890300a' target=_blank style='color:#2F92EE;'>#血小板增多症#</a>, objectTitle=Blood：羟基脲 vs 聚乙二醇化IFN-α 治疗原发性血小板增多症/真性红细胞增多症, objectType=article, longId=727286, objectId=b019e27286d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b019e27286d3, replyNumber=0, likeNumber=62, createdTime=2022-12-20, rootId=0, userName=achengzhao, userId=e656479, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b019e27286d3, moduleTitle=Blood：羟基脲 vs 聚乙二醇化IFN-α 治疗原发性血小板增多症/真性红细胞增多症, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b019e27286d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2028511, encodeId=f1d620285114b, content=<a href='/topic/show?id=b3eb890300a' target=_blank style='color:#2F92EE;'>#血小板增多症#</a>, objectTitle=BJH：原发性血小板增多症患者的减细胞治疗及其与血小板功能和成熟度的关系, objectType=article, longId=729556, objectId=ba9fe29556e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba9fe29556e5, replyNumber=0, likeNumber=71, createdTime=2022-11-30, rootId=0, userName=achengzhao, userId=e656479, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba9fe29556e5, moduleTitle=BJH：原发性血小板增多症患者的减细胞治疗及其与血小板功能和成熟度的关系, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ba9fe29556e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2028509, encodeId=0e7320285090f, content=<a href='/topic/show?id=b3eb890300a' target=_blank style='color:#2F92EE;'>#血小板增多症#</a>, objectTitle=Leukemia ：罗特西普用于骨髓增生异常综合征/骨髓增生性肿瘤伴环状铁粒幼细胞和血小板增多症, objectType=article, longId=299893, objectId=d33a2998931b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d33a2998931b, replyNumber=0, likeNumber=98, createdTime=2022-09-21, rootId=0, userName=achengzhao, userId=e656479, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d33a2998931b, moduleTitle=Leukemia ：罗特西普用于骨髓增生异常综合征/骨髓增生性肿瘤伴环状铁粒幼细胞和血小板增多症, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d33a2998931b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2028507, encodeId=0352202850eb0, content=<a href='/topic/show?id=b3eb890300a' target=_blank style='color:#2F92EE;'>#血小板增多症#</a>, objectTitle=Blood：三种阿司匹林治疗方案在优化特发性血小板增多症患者抗血小板治疗比较, objectType=article, longId=191811, objectId=2d0619181140, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d0619181140, replyNumber=0, likeNumber=84, createdTime=2020-07-27, rootId=0, userName=achengzhao, userId=e656479, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d0619181140, moduleTitle=Blood：三种阿司匹林治疗方案在优化特发性血小板增多症患者抗血小板治疗比较, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2d0619181140)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2028508, encodeId=f8a32028508f5, content=<a href='/topic/show?id=b3eb890300a' target=_blank style='color:#2F92EE;'>#血小板增多症#</a>, objectTitle=Blood：针对特发性血小板增多症，阿司匹林优化抗血小板疗法的更佳用药方案, objectType=article, longId=192298, objectId=b2fa1922980b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2fa1922980b, replyNumber=0, likeNumber=102, createdTime=2020-11-11, rootId=0, userName=achengzhao, userId=e656479, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2fa1922980b, moduleTitle=Blood：针对特发性血小板增多症，阿司匹林优化抗血小板疗法的更佳用药方案, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b2fa1922980b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2028506, encodeId=c5b1202850619, content=<a href='/topic/show?id=b3eb890300a' target=_blank style='color:#2F92EE;'>#血小板增多症#</a>, objectTitle=Blood：原发性血小板增多症的MPL基因突变揭示了一条依赖于W491的共有激活通路, objectType=article, longId=187109, objectId=ad8918e10955, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad8918e10955, replyNumber=0, likeNumber=71, createdTime=2020-11-12, rootId=0, userName=achengzhao, userId=e656479, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad8918e10955, moduleTitle=Blood：原发性血小板增多症的MPL基因突变揭示了一条依赖于W491的共有激活通路, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ad8918e10955)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2028505, encodeId=1ae22028505e2, content=<a href='/topic/show?id=b3eb890300a' target=_blank style='color:#2F92EE;'>#血小板增多症#</a>, objectTitle=血小板增多症如何治疗？, objectType=article, longId=176344, objectId=0ad81e63447e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ad81e63447e, replyNumber=0, likeNumber=102, createdTime=2020-01-06, rootId=0, userName=achengzhao, userId=e656479, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ad81e63447e, moduleTitle=血小板增多症如何治疗？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0ad81e63447e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2028504, encodeId=4d5c2028504e4, content=<a href='/topic/show?id=b3eb890300a' target=_blank style='color:#2F92EE;'>#血小板增多症#</a>, objectTitle=J Clin Oncol:原发性血小板增多症：羟基脲与阿司匹林联用效果如何？, objectType=article, longId=149862, objectId=829b14986267, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=829b14986267, replyNumber=0, likeNumber=84, createdTime=2019-05-18, rootId=0, userName=achengzhao, userId=e656479, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=829b14986267, moduleTitle=J Clin Oncol:原发性血小板增多症：羟基脲与阿司匹林联用效果如何？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=829b14986267)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2028503, encodeId=23f020285038b, content=<a href='/topic/show?id=b3eb890300a' target=_blank style='color:#2F92EE;'>#血小板增多症#</a>, objectTitle=儿童高白细胞性B淋巴细胞白血病治疗中继发血小板增多症1例报告, objectType=article, longId=137175, objectId=ab6213e1753d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab6213e1753d, replyNumber=0, likeNumber=75, createdTime=2018-06-14, rootId=0, userName=achengzhao, userId=e656479, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab6213e1753d, moduleTitle=儿童高白细胞性B淋巴细胞白血病治疗中继发血小板增多症1例报告, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ab6213e1753d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2028502, encodeId=fcf1202850218, content=<a href='/topic/show?id=b3eb890300a' target=_blank style='color:#2F92EE;'>#血小板增多症#</a>, objectTitle=Blood：卢索替尼治疗对羟基尿素有耐药性的原发性血小板增多症的效果。, objectType=article, longId=108548, objectId=86f610854833, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=86f610854833, replyNumber=0, likeNumber=64, createdTime=2017-11-22, rootId=0, userName=achengzhao, userId=e656479, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=86f610854833, moduleTitle=Blood：卢索替尼治疗对羟基尿素有耐药性的原发性血小板增多症的效果。, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=86f610854833)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2028501, encodeId=3ebd202850188, content=<a href='/topic/show?id=b3eb890300a' target=_blank style='color:#2F92EE;'>#血小板增多症#</a>, objectTitle=Ann Intern Med：原发性血小板增多症抗血栓治疗的益处和风险！, objectType=article, longId=104445, objectId=f1ee10444578, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1ee10444578, replyNumber=0, likeNumber=75, createdTime=2017-11-14, rootId=0, userName=achengzhao, userId=e656479, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1ee10444578, moduleTitle=Ann Intern Med：原发性血小板增多症抗血栓治疗的益处和风险！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f1ee10444578)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2028500, encodeId=a8d82028500bd, content=<a href='/topic/show?id=b3eb890300a' target=_blank style='color:#2F92EE;'>#血小板增多症#</a>, objectTitle=原发性血小板增多症诊断与治疗中国专家共识(2016年版), objectType=article, longId=81729, objectId=ade081e29da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ade081e29da, replyNumber=0, likeNumber=66, createdTime=2017-01-18, rootId=0, userName=achengzhao, userId=e656479, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ade081e29da, moduleTitle=原发性血小板增多症诊断与治疗中国专家共识(2016年版), moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ade081e29da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2028499, encodeId=05ae202849908, content=<a href='/topic/show?id=b3eb890300a' target=_blank style='color:#2F92EE;'>#血小板增多症#</a>, objectTitle=NEJM：端粒酶抑制剂imetelstat用于骨髓纤维化和原发性血小板增多症疗效乐观（2期临床）, objectType=article, longId=55964, objectId=362d559648b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=362d559648b, replyNumber=0, likeNumber=65, createdTime=2015-10-09, rootId=0, userName=achengzhao, userId=e656479, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=362d559648b, moduleTitle=NEJM：端粒酶抑制剂imetelstat用于骨髓纤维化和原发性血小板增多症疗效乐观（2期临床）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=362d559648b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2028498, encodeId=bb59202849898, content=<a href='/topic/show?id=b3eb890300a' target=_blank style='color:#2F92EE;'>#血小板增多症#</a>, objectTitle=CSMO 2014 ：恶性实体肿瘤继发血小板增多症研究现状, objectType=article, longId=37609, objectId=1bca3e609d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1bca3e609d8, replyNumber=0, likeNumber=62, createdTime=2015-04-23, rootId=0, userName=achengzhao, userId=e656479, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1bca3e609d8, moduleTitle=CSMO 2014 ：恶性实体肿瘤继发血小板增多症研究现状, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1bca3e609d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2028497, encodeId=392c202849edf, content=<a href='/topic/show?id=b3eb890300a' target=_blank style='color:#2F92EE;'>#血小板增多症#</a>, objectTitle=Cell：单细胞测序新方法研究原发性血小板增多症获进展, objectType=article, longId=4330, objectId=c912433044, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c912433044, replyNumber=0, likeNumber=99, createdTime=2012-10-18, rootId=0, userName=achengzhao, userId=e656479, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c912433044, moduleTitle=Cell：单细胞测序新方法研究原发性血小板增多症获进展, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c912433044)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

血小板增多症

2020-05-29

achengzhao (审核中...)

前往app查看评论内容

#血小板增多症#

Blood：羟基脲 vs 聚乙二醇化IFN-α 治疗原发性血小板增多症/真性红细胞增多症

2022-12-20

achengzhao (审核中...)

前往app查看评论内容

#血小板增多症#

BJH：原发性血小板增多症患者的减细胞治疗及其与血小板功能和成熟度的关系

2022-11-30

achengzhao (审核中...)

前往app查看评论内容

#血小板增多症#

Leukemia ：罗特西普用于骨髓增生异常综合征/骨髓增生性肿瘤伴环状铁粒幼细胞和血小板增多症

2022-09-21

achengzhao (审核中...)

前往app查看评论内容

#血小板增多症#

Blood：三种阿司匹林治疗方案在优化特发性血小板增多症患者抗血小板治疗比较

2020-07-27

achengzhao (审核中...)

前往app查看评论内容

#血小板增多症#

Blood：针对特发性血小板增多症，阿司匹林优化抗血小板疗法的更佳用药方案

2020-11-11

achengzhao (审核中...)

前往app查看评论内容

#血小板增多症#

Blood：原发性血小板增多症的MPL基因突变揭示了一条依赖于W491的共有激活通路

2020-11-12

achengzhao (审核中...)

前往app查看评论内容

#血小板增多症#

血小板增多症如何治疗？

2020-01-06

achengzhao (审核中...)

前往app查看评论内容

#血小板增多症#

J Clin Oncol:原发性血小板增多症：羟基脲与阿司匹林联用效果如何？

2019-05-18

achengzhao (审核中...)

前往app查看评论内容

#血小板增多症#

儿童高白细胞性B淋巴细胞白血病治疗中继发血小板增多症1例报告

2018-06-14

achengzhao (审核中...)

前往app查看评论内容

#血小板增多症#

Blood：卢索替尼治疗对羟基尿素有耐药性的原发性血小板增多症的效果。

2017-11-22

achengzhao (审核中...)

前往app查看评论内容

#血小板增多症#

Ann Intern Med：原发性血小板增多症抗血栓治疗的益处和风险！

2017-11-14

achengzhao (审核中...)

前往app查看评论内容

#血小板增多症#

原发性血小板增多症诊断与治疗中国专家共识(2016年版)

2017-01-18

achengzhao (审核中...)

前往app查看评论内容

#血小板增多症#

NEJM：端粒酶抑制剂imetelstat用于骨髓纤维化和原发性血小板增多症疗效乐观（2期临床）

2015-10-09

achengzhao (审核中...)

前往app查看评论内容

#血小板增多症#

CSMO 2014 ：恶性实体肿瘤继发血小板增多症研究现状

2015-04-23

achengzhao (审核中...)

前往app查看评论内容

#血小板增多症#

Cell：单细胞测序新方法研究原发性血小板增多症获进展

2012-10-18

科室
- - 订阅+
  - 更多科室
工具
服务